You are here: Home / Research / Resources / Third Party Funding and Consortia

Third Party Funding and Consortia

Scientists of the Cluster are partners in large consortia of nationa and international funding agencies.

Selected Third Party Funding and Consortia


  • SFB 877 "Proteolysis as a Regulatory Event in Pathophysiology"
  • SFB 654 "Plasticity and Sleep"
  • SFB/TR22 "Pulmonary Allergies"
  • SFB 841 "Liver Inflammation – Infection,Immunoregulation and Consequences"
  • KFO 170 "Early Pathogenesis of the Wegner Granulomatose"
  • GRK 1727 "Modulation of Autoimmunity"


  • Popgen 2.0
  • Networks on Resistance and Susceptibility of Infectious Diseases "TBornotTB"
  • International Cancer Genome Consortium "Determination of molecular mechnisms of malignand lymphoma"
  • National Competence Network "Inflammatory Bowel Disease" and "Focus Food Chain Plus"
  • NGFN-Plus "Environment related diseases", "Large intestine cancer" and "Atherogenomics"
  • NaoCare "Prediction of the toxicological potentiel for humans of synthetic Carbon black nano particles"
  • National Cohort
  • German Centre for Lung Research
  • German Centre for Infection Research


  • ESGI "European Sequencing and Genotyping Infrastructure"
  • "Clinical Development of Enzyme Replacement Therapy in Alpha-Mannosidosis patients using recombinant human enzyme"
  • ReaDNA "Revolutionary Approaches and Devices for Nucleic Acid analysis"
  • gEuvadis "Genetic European Variation in Disease"
  • RESOLVE "Resolve Chronic Inflammation and Achieve Healthy Aging by Understanding Non-regenerative Repair"
  • Cardiogenics
  • ENGAGE "European Network of Genomic and Genetic Epidemiology"

Document Actions